These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 36926710)
1. Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease. Hertzog N; Jacob C Neural Regen Res; 2023 Sep; 18(9):1931-1939. PubMed ID: 36926710 [TBL] [Abstract][Full Text] [Related]
2. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Klein D; Patzkó Á; Schreiber D; van Hauwermeiren A; Baier M; Groh J; West BL; Martini R Brain; 2015 Nov; 138(Pt 11):3193-205. PubMed ID: 26297559 [TBL] [Abstract][Full Text] [Related]
4. Inherited demyelinating neuropathies with micromutations of peripheral myelin protein 22 gene. Taioli F; Cabrini I; Cavallaro T; Acler M; Fabrizi GM Brain; 2011 Feb; 134(Pt 2):608-17. PubMed ID: 21252112 [TBL] [Abstract][Full Text] [Related]
5. Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model. Florio F; Ferri C; Scapin C; Feltri ML; Wrabetz L; D'Antonio M J Neurosci; 2018 May; 38(18):4275-4287. PubMed ID: 29610440 [TBL] [Abstract][Full Text] [Related]
6. A rat model of Charcot-Marie-Tooth disease 1A recapitulates disease variability and supplies biomarkers of axonal loss in patients. Fledrich R; Schlotter-Weigel B; Schnizer TJ; Wichert SP; Stassart RM; Meyer zu Hörste G; Klink A; Weiss BG; Haag U; Walter MC; Rautenstrauss B; Paulus W; Rossner MJ; Sereda MW Brain; 2012 Jan; 135(Pt 1):72-87. PubMed ID: 22189569 [TBL] [Abstract][Full Text] [Related]
7. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A. Saporta MA; Katona I; Lewis RA; Masse S; Shy ME; Li J Brain; 2009 Dec; 132(Pt 12):3263-73. PubMed ID: 19923170 [TBL] [Abstract][Full Text] [Related]
8. A new mouse model of Charcot-Marie-Tooth 2J neuropathy replicates human axonopathy and suggest alteration in axo-glia communication. Shackleford G; Marziali LN; Sasaki Y; Claessens A; Ferri C; Weinstock NI; Rossor AM; Silvestri NJ; Wilson ER; Hurley E; Kidd GJ; Manohar S; Ding D; Salvi RJ; Feltri ML; D'Antonio M; Wrabetz L PLoS Genet; 2022 Nov; 18(11):e1010477. PubMed ID: 36350884 [TBL] [Abstract][Full Text] [Related]
9. Schwann Cell and the Pathogenesis of Charcot-Marie-Tooth Disease. Murakami T; Sunada Y Adv Exp Med Biol; 2019; 1190():301-321. PubMed ID: 31760652 [TBL] [Abstract][Full Text] [Related]
10. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. Saporta MA; Shy BR; Patzko A; Bai Y; Pennuto M; Ferri C; Tinelli E; Saveri P; Kirschner D; Crowther M; Southwood C; Wu X; Gow A; Feltri ML; Wrabetz L; Shy ME Brain; 2012 Jul; 135(Pt 7):2032-47. PubMed ID: 22689911 [TBL] [Abstract][Full Text] [Related]
11. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Niemann A; Berger P; Suter U Neuromolecular Med; 2006; 8(1-2):217-42. PubMed ID: 16775378 [TBL] [Abstract][Full Text] [Related]
12. Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. Vavlitou N; Sargiannidou I; Markoullis K; Kyriacou K; Scherer SS; Kleopa KA J Neuropathol Exp Neurol; 2010 Sep; 69(9):945-58. PubMed ID: 20720503 [TBL] [Abstract][Full Text] [Related]
13. c-Jun activation in Schwann cells protects against loss of sensory axons in inherited neuropathy. Hantke J; Carty L; Wagstaff LJ; Turmaine M; Wilton DK; Quintes S; Koltzenburg M; Baas F; Mirsky R; Jessen KR Brain; 2014 Nov; 137(Pt 11):2922-37. PubMed ID: 25216747 [TBL] [Abstract][Full Text] [Related]
14. Schwann cells and the pathogenesis of inherited motor and sensory neuropathies (Charcot-Marie-Tooth disease). Berger P; Niemann A; Suter U Glia; 2006 Sep; 54(4):243-57. PubMed ID: 16856148 [TBL] [Abstract][Full Text] [Related]
15. New evidence for secondary axonal degeneration in demyelinating neuropathies. Moss KR; Bopp TS; Johnson AE; Höke A Neurosci Lett; 2021 Jan; 744():135595. PubMed ID: 33359733 [TBL] [Abstract][Full Text] [Related]
16. Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene. Sanmaneechai O; Feely S; Scherer SS; Herrmann DN; Burns J; Muntoni F; Li J; Siskind CE; Day JW; Laura M; Sumner CJ; Lloyd TE; Ramchandren S; Shy RR; Grider T; Bacon C; Finkel RS; Yum SW; Moroni I; Piscosquito G; Pareyson D; Reilly MM; Shy ME; Brain; 2015 Nov; 138(Pt 11):3180-92. PubMed ID: 26310628 [TBL] [Abstract][Full Text] [Related]
17. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Hattori N; Yamamoto M; Yoshihara T; Koike H; Nakagawa M; Yoshikawa H; Ohnishi A; Hayasaka K; Onodera O; Baba M; Yasuda H; Saito T; Nakashima K; Kira J; Kaji R; Oka N; Sobue G; Brain; 2003 Jan; 126(Pt 1):134-51. PubMed ID: 12477701 [TBL] [Abstract][Full Text] [Related]
18. Charcot-Marie-Tooth disease: an update. Shy ME Curr Opin Neurol; 2004 Oct; 17(5):579-85. PubMed ID: 15367862 [TBL] [Abstract][Full Text] [Related]
19. Charcot-Marie-Tooth neuropathy: clinical phenotypes of four novel mutations in the MPZ and Cx 32 genes. Street VA; Meekins G; Lipe HP; Seltzer WK; Carter GT; Kraft GH; Bird TD Neuromuscul Disord; 2002 Oct; 12(7-8):643-50. PubMed ID: 12207932 [TBL] [Abstract][Full Text] [Related]
20. Calcineurin Activity Is Increased in Charcot-Marie-Tooth 1B Demyelinating Neuropathy. Sidoli M; Reed CB; Scapin C; Paez P; Cavener DR; Kaufman RJ; D'Antonio M; Feltri ML; Wrabetz L J Neurosci; 2021 May; 41(20):4536-4548. PubMed ID: 33879538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]